Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selenoproteins | 4 | 2022 | 151 | 2.240 |
Why?
|
| T-Lymphocytes | 4 | 2022 | 341 | 2.140 |
Why?
|
| Osteoarthritis | 3 | 2021 | 17 | 2.090 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 4 | 2020 | 9 | 1.770 |
Why?
|
| Ethanolamine | 2 | 2021 | 8 | 1.620 |
Why?
|
| Phospholipids | 2 | 2021 | 68 | 1.540 |
Why?
|
| Chondrocytes | 3 | 2021 | 15 | 1.170 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 2015 | 4 | 1.000 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2015 | 52 | 0.980 |
Why?
|
| Dendritic Cells | 2 | 2015 | 112 | 0.930 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2022 | 6 | 0.880 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2020 | 166 | 0.860 |
Why?
|
| Selenium | 2 | 2021 | 144 | 0.840 |
Why?
|
| Ethanolaminephosphotransferase | 1 | 2021 | 4 | 0.840 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 2 | 2018 | 10 | 0.840 |
Why?
|
| Lymphocyte Activation | 2 | 2022 | 222 | 0.820 |
Why?
|
| DNA Damage | 3 | 2020 | 341 | 0.810 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2018 | 5 | 0.790 |
Why?
|
| Metabolism | 1 | 2020 | 9 | 0.780 |
Why?
|
| Genomic Instability | 1 | 2020 | 34 | 0.770 |
Why?
|
| Signal Transduction | 8 | 2019 | 1802 | 0.690 |
Why?
|
| Oxidative Stress | 3 | 2021 | 874 | 0.670 |
Why?
|
| Hyperhomocysteinemia | 1 | 2018 | 4 | 0.650 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2015 | 9 | 0.650 |
Why?
|
| Sirtuin 1 | 1 | 2018 | 32 | 0.640 |
Why?
|
| Proteins | 1 | 2020 | 352 | 0.630 |
Why?
|
| Polyadenylation | 1 | 2018 | 48 | 0.630 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 14 | 0.630 |
Why?
|
| Protein Kinases | 1 | 2018 | 91 | 0.620 |
Why?
|
| Inflammation | 2 | 2021 | 577 | 0.600 |
Why?
|
| Interleukin-12 | 2 | 2015 | 46 | 0.590 |
Why?
|
| Mice, Knockout | 5 | 2022 | 897 | 0.570 |
Why?
|
| Interleukin-6 | 2 | 2015 | 140 | 0.560 |
Why?
|
| Mice | 9 | 2022 | 5668 | 0.550 |
Why?
|
| DNA Methylation | 1 | 2018 | 301 | 0.530 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 528 | 0.530 |
Why?
|
| Interferon Type I | 1 | 2015 | 17 | 0.530 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 781 | 0.480 |
Why?
|
| Up-Regulation | 3 | 2021 | 490 | 0.480 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2013 | 4 | 0.460 |
Why?
|
| Neoplasms | 2 | 2018 | 1033 | 0.410 |
Why?
|
| Phosphatidylethanolamines | 2 | 2021 | 22 | 0.410 |
Why?
|
| Animals | 11 | 2022 | 14307 | 0.400 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1442 | 0.390 |
Why?
|
| Metabolomics | 2 | 2021 | 76 | 0.350 |
Why?
|
| Humans | 14 | 2022 | 34853 | 0.330 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1426 | 0.330 |
Why?
|
| Cell Differentiation | 2 | 2022 | 562 | 0.330 |
Why?
|
| Phosphorylation | 3 | 2017 | 878 | 0.320 |
Why?
|
| Fanconi Anemia | 2 | 2017 | 12 | 0.320 |
Why?
|
| Protein Binding | 3 | 2020 | 913 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 1530 | 0.270 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1149 | 0.260 |
Why?
|
| Mitochondria | 2 | 2018 | 454 | 0.240 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 40 | 0.230 |
Why?
|
| Apoptosis | 2 | 2021 | 1317 | 0.230 |
Why?
|
| NF-kappa B | 2 | 2017 | 306 | 0.220 |
Why?
|
| Interleukin-17 | 1 | 2022 | 54 | 0.220 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 74 | 0.210 |
Why?
|
| Galectin 3 | 1 | 2021 | 26 | 0.210 |
Why?
|
| Galectins | 1 | 2021 | 27 | 0.210 |
Why?
|
| Blood Proteins | 1 | 2021 | 65 | 0.210 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 58 | 0.200 |
Why?
|
| Selenocysteine | 1 | 2021 | 52 | 0.200 |
Why?
|
| Ethanolamines | 1 | 2021 | 12 | 0.200 |
Why?
|
| Cyclooxygenase 2 | 2 | 2019 | 92 | 0.200 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2021 | 19 | 0.200 |
Why?
|
| Lipogenesis | 1 | 2021 | 18 | 0.200 |
Why?
|
| Protein Stability | 1 | 2020 | 40 | 0.190 |
Why?
|
| Glycolysis | 1 | 2021 | 66 | 0.190 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 65 | 0.190 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 147 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 162 | 0.190 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 116 | 0.190 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 195 | 0.180 |
Why?
|
| Phenotype | 1 | 2022 | 650 | 0.180 |
Why?
|
| Matrix Metalloproteinases | 1 | 2019 | 44 | 0.180 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 15 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 325 | 0.170 |
Why?
|
| Chromosomal Instability | 1 | 2018 | 21 | 0.170 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2018 | 3 | 0.170 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 1300 | 0.170 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 120 | 0.160 |
Why?
|
| Colitis | 1 | 2019 | 64 | 0.160 |
Why?
|
| Homocysteine | 1 | 2018 | 18 | 0.160 |
Why?
|
| Models, Genetic | 1 | 2018 | 149 | 0.160 |
Why?
|
| Cartilage, Articular | 1 | 2017 | 9 | 0.160 |
Why?
|
| Poly I-C | 1 | 2017 | 7 | 0.160 |
Why?
|
| PPAR gamma | 1 | 2018 | 49 | 0.160 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2017 | 7 | 0.160 |
Why?
|
| Histones | 1 | 2018 | 177 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 90 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 181 | 0.150 |
Why?
|
| Mutation | 2 | 2018 | 1023 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2022 | 386 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2017 | 110 | 0.150 |
Why?
|
| RNA Interference | 1 | 2017 | 225 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 180 | 0.140 |
Why?
|
| Energy Metabolism | 1 | 2017 | 160 | 0.140 |
Why?
|
| DNA Repair | 1 | 2017 | 181 | 0.140 |
Why?
|
| Time Factors | 1 | 2020 | 1681 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 968 | 0.140 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2015 | 6 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2015 | 6 | 0.130 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 15 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 26 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 416 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 53 | 0.130 |
Why?
|
| Female | 4 | 2021 | 19873 | 0.120 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2013 | 5 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 245 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 126 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2013 | 170 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2013 | 392 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 522 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 445 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2022 | 420 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2022 | 391 | 0.080 |
Why?
|
| Male | 3 | 2021 | 18870 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 1 | 2022 | 26 | 0.060 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2022 | 14 | 0.050 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2022 | 27 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 96 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 57 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 67 | 0.050 |
Why?
|
| Autophagy | 1 | 2022 | 111 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 2128 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 184 | 0.050 |
Why?
|
| Tendinopathy | 1 | 2019 | 3 | 0.050 |
Why?
|
| Silicon Dioxide | 1 | 2019 | 33 | 0.050 |
Why?
|
| Interleukin-16 | 1 | 2019 | 4 | 0.040 |
Why?
|
| Antibodies | 1 | 2019 | 135 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 60 | 0.040 |
Why?
|
| Actins | 1 | 2019 | 142 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 204 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 139 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 79 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2018 | 310 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2017 | 33 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 555 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 237 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 859 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 162 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2017 | 207 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 485 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 597 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1534 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 1124 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 639 | 0.030 |
Why?
|
| Rats | 1 | 2019 | 3261 | 0.030 |
Why?
|